Unusual presentation of tumor‐induced osteomalacia mismanaged due to misdiagnosis: A literature review based on a case report

• Published in: Clinical case reports 2024-05, Vol.12 (5), p.e8885-n/a
• Main Authors: Fatollahzadeh, Mahdieh, Meybodi, Hamid Reza Aghaei, Pajavand, Hamid, Payab, Moloud, Ebrahimpur, Mahbube, Ebrahimi, Pouya
• Format: Article
• Language: English
• Subjects: Acute Medicine; Ankle; Bone cancer; Bone density; bone tumor; Cardiology; Case Report; Case reports; Disease; Endocrinology and Metabolic Disorders; fracture; Fractures; Laboratories; Medical research; Mineralization; musculoskeletal; Neurosurgery; oncology; Osteoporosis; Pain; phosphate; Phosphorus; Radiation therapy; Surgery; Tumors; tumor‐induced Osteomalacia; Vitamin D; Vitamin deficiency
• ISSN: 2050-0904; 2050-0904
• DOI: 10.1002/ccr3.8885

Key Clinical Message Tumor‐induced osteomalacia is a rare but potentially serious disease with nonspecific misguiding manifestations that can result in a wrong diagnosis and being treated for rheumatologic or other similar diseases. In patients with unexpected fractures, resistant musculoskeletal pains, and hypophosphatemia, this diagnosis should be considered by the physicians and approached through a complete history taking, physical exam laboratory, and radiologic evaluation to give the opportunity of on‐time treatment to the patient. Tumor‐induced osteomalacia (TIO) is an uncommon mesenchymal tumor that results in disproportionate phosphorus excretion, primarily leading to bone‐related symptoms. Laboratory, imaging, and histopathological evaluation can confirm this pathologic condition. In this case, we present the history and subsequent clinical parts of a 50‐year‐old woman who presented with an unusual presentation of generalized musculoskeletal pains and a right ankle mass. Her disease was diagnosed with multidisciplinary evaluation and was approached by a surgical treatment. The patient was treated with total resection of the tumor, which led to complete resolution of musculoskeletal and metabolic abnormalities, which were resolved following total tumor resection. TIO is a paraneoplastic disease that results in abnormal secretion of phosphatonins, particularly fibroblast growth factor 23 (FGF23). This can cause hypophosphatemia, hyperparathyroidism, lower bone density, and increased risk of pathologic fractures. These tumors are mostly cured by surgical ± radiotherapy. The present study aims to provide insight into the fact that a TIO diagnosis is not always straightforward. However, in suspicious cases such as unexplained hypophosphatemia, it should be considered to prevent delayed diagnosis of the progressive pathology. The earlier treatment can prevent several complications and reduce the risk of mortality.